Health Insurance Literacy and Challenges in Accessing Health Services in Niemann-Pick

NCT ID: NCT04469894

Last Updated: 2020-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

76 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-15

Study Completion Date

2020-09-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a US based qualitative PRO research study to document the health insurance literacy as well as the patient experience in Niemann-Pick as it relates to accessing desired care, services and medications for patients.

The outcome of this research will be used to inform various other workstreams as NNPDF works to assist families.

The core research objectives are to understand the following from Niemann-Pick patients and their families in the US

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a US based qualitative PRO research study to document the health insurance literacy as well as the patient experience in Niemann-Pick as it relates to accessing desired care, services and medications for patients.

The outcome of this research will be used to inform various other workstreams as NNPDF works to assist families.

The core research objectives are to understand the following from Niemann-Pick patients and their families in the US;

* Level of health insurance literacy through assessment of health insurance terminology, and self-reported insights regarding information seeking, document literacy and cognitive skills
* If they have healthcare insurance, and if not, why not
* Types (including name) of insurance by which Niemann-Pick families are covered
* Information regarding Medicaid Waivers
* Attributes of insurance plans including, but not limited to;

* Deductible amounts for individual and family
* Out of pocket maximums for individual and family
* Insurance premiums
* Associated Health Savings Accounts
* Associated Cost Sharing requirements
* Services, drugs and assistive devices covered
* What the perceived out-of-pocket costs are for Niemann-Pick families (annually)
* When out-of-pocket maximums are perceived to be met for Niemann-Pick families
* Patient and HCP experience in terms of challenges with accessing desired care and coverage

* Where are families experiencing challenges with accessing desired care and coverage? (drugs, assistive devices, services) Is it different for the different phenotypes of the disease?
* What is the challenge? (financial, time, stress, others)
* What is the life impact of that challenge? (work and educational impact, lack or delay of treatment, others)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Niemann-Pick Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Niemann-Pick Type A

Also referred to as Infantile Neurovisceral ASMD

No interventions assigned to this group

Niemann-Pick Type A/B

Also referred to as Intermediate form or Chronic Neurovisceral ASMD

No interventions assigned to this group

Niemann-Pick Type B

Also referred to as Chronic Visceral ASMD

No interventions assigned to this group

Niemann-Pick Type C (Early Infantile)

Onset at less than 2 years of age

No interventions assigned to this group

Niemann-Pick Type C (Late Infantile)

Neurodegenerative form (late-infantile) onset at 2-6 years of age

No interventions assigned to this group

Niemann-Pick Type C (Juvenile)

Neurodegenerative form (juvenile) onset at 6-15 years of age

No interventions assigned to this group

Niemann-Pick Type C (Adult)

Psychiatric neurodegenerative form (adult) onset at greater than 15 years of age

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant must be a person with Niemann-Pick disease who is 18 years or older or The parent/legal guardian of a person with Niemann-Pick disease. Please note: Parents whose child has passed on are able to participate in the RSVP. Parents whose child has passed on in the last two years are also able to participate in the interview. Please note that only one family member will be eligible to complete the RSVP and interview for one family.
* Confirmed diagnosis of Niemann-Pick disease, confirmed by membership in the NNPDF or by provision of a proof of disease form
* Able to read, write and communicate in English
* Able to grant informed consent
* Willing to complete a survey and RSVP, and to participate in a 30-minute telephone interview
* Ability to view or receive a document from the interviewer before or during the interview (web browser, ability to receive a text, fax or document by mail)

Exclusion Criteria

\- Inability to meet any of the above 6 criteria
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Engage Health Inc.

INDUSTRY

Sponsor Role collaborator

Icahn School of Medicine at Mount Sinai

OTHER

Sponsor Role collaborator

National Niemann-Pick Disease Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George A Diaz, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Icahn School of Medicine at Mount Sinai

Justin Hopkin, MD

Role: STUDY_CHAIR

National Niemann-Pick Disease Board Chair

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NNPDF-BUR001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Positive Angle Kappa
NCT01644552 COMPLETED
Podocyts Integrity in Glomerular Diseases
NCT05875454 NOT_YET_RECRUITING